http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AP-9801174-A0

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
filingDate 1998-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3428e61a47f0245cc54efb00029e30b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_856786b4eeea68a82d1a4c2b06a94945
publicationDate 1998-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AP-9801174-A0
titleOfInvention Cyclic sulfone derivatives.
abstract A compound of the formula i wherein n,x,y and ar are as defined herein, useful in the treatment of a condition selected from the group consisiting of arthritis, cancer, tissue ulceration, macular degeneration, restenosis, periodontal disease, epidemolysis bullosa, scleritis, and other diseases characterized by matrix metalloproteinase activity, aids, sepsis, septic shock and other diseases involving the production of tnf. In addition, the compounds of the oresent invention may be used in combination therapy with standard non-steroidal anti-inflammatory drugs (nsaid's)and analgesics, and in combination with cytotoxic drugs such as adriamycin, daunomycin, cis-plantinum, etoposide, taxol, taxotere and other alksloids, such as vincristine, in the treatment of cancer.
priorityDate 1997-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30323
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535646
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504230

Total number of triples: 36.